ALICIA
RODRIGUEZ GASCON
UNIBERTSITATEKO KATEDRADUNA
JULEN
RODRIGUEZ CASTEJON
Ikertzaileren 2020-2024 tartean
JULEN RODRIGUEZ CASTEJON-rekin lankidetzan egindako argitalpenak (17)
2024
-
Gene therapy with lipid nanoparticles for Fabry disease: Leveraging E-selectin for targeted delivery to endothelial cells
Journal of Drug Delivery Science and Technology, Vol. 99
-
Targeting strategies with lipid vectors for nucleic acid supplementation therapy in Fabry disease: a systematic review
Drug Delivery and Translational Research
2023
-
Expression of a conserved sequence of SARS-CoV-2 for panβ-coronavirus vaccine development
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
Nanopartículas lipídicas funcionalizadas con GalNAc para suplementación génica: aplicación en la enfermedad de Fabry
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
-
Novel Golden Lipid Nanoparticles with Small Interference Ribonucleic Acid for Substrate Reduction Therapy in Fabry Disease
Pharmaceutics, Vol. 15, Núm. 7
-
siRNA vectors based on golden lipid nanoparticles for Fabry Disease
XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones
2022
-
Galactomannan-Decorated Lipidic Nanocarrier for Gene Supplementation Therapy in Fabry Disease
Nanomaterials, Vol. 12, Núm. 14
-
mRNA delivery technologies: Toward clinical translation
International Review of Cell and Molecular Biology (Elsevier Inc.), pp. 207-293
2021
-
Functionalised SLNs-based nanovectors for gene therapy in Fabry disease: The liver as an α-Galactosidase A factory
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 46-48
-
Mrna-based nanomedicinal products to address corneal inflammation by interleukin-10 supplementation
Pharmaceutics, Vol. 13, Núm. 9
-
Substrate reduction therapy based on siRNA for Fabry Disease
RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 84-86
-
α-Galactosidase A Augmentation by Non-Viral Gene Therapy: Evaluation in Fabry Disease Mice
Pharmaceutics, Vol. 13, Núm. 6
2020
-
Gene Therapy
Advances in Biochemical Engineering/Biotechnology (Springer), pp. 321-368
-
Nanomedicines to deliver mRNA: State of the art and future perspectives
Nanomaterials, Vol. 10, Núm. 2
-
Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA
Molecules (Basel, Switzerland), Vol. 25, Núm. 24
-
Topical administration of sln-based gene therapy for the treatment of corneal inflammation by de novo il-10 production
Pharmaceutics, Vol. 12, Núm. 6, pp. 1-23
2019
-
Gene-terapia: ikuspegi terapeutiko berria begietako gaitzen tratamenduan
Ekaia: Euskal Herriko Unibertsitateko zientzi eta teknologi aldizkaria, Núm. 36, pp. 31-48